Suppression of calpain expression by NSAIDs is associated with inhibition of cell migration in rat duodenum.
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for the alleviation of pain and inflammation, but these drugs are also associated with a suite of negative side effects. Gastrointestinal (GI) toxicity is particularly concerning since it affects an estimated 70% of individuals taking NSAIDs routinely, and evidence suggests the majority of toxicity is occurring in the small intestine. Traditionally, NSAID-induced GI toxicity has been associated with indiscriminate inhibition of cyclooxygenase isoforms, but other mechanisms, including inhibition of cell migration, intestinal restitution, and wound healing, are likely to contribute to toxicity. Previous efforts demonstrated that treatment of cultured intestinal epithelial cells (IEC) with NSAIDs inhibits expression and activity of calpain proteases, but the effects of specific inhibition of calpain expression in vitro or the effects of NSAIDs on intestinal cell migration in vivo remain to be determined. Accordingly, we examined the effect of suppression of calpain protease expression with siRNA on cell migration in cultured IECs and evaluated the effects of NSAID treatment on epithelial cell migration and calpain protease expression in rat duodenum. Our results show that calpain siRNA inhibits protease expression and slows migration in cultured IECs. Additionally, NSAID treatment of rats slowed migration up the villus axis and suppressed calpain expression in duodenal epithelial cells. Our results are supportive of the hypothesis that suppression of calpain expression leading to slowing of cell migration is a potential mechanism through which NSAIDs cause GI toxicity.
Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, USA. Electronic address: ksilver@ksu.edu.
Kristopher
K
Silver
Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, USA.
A
A
Littlejohn
Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, USA.
Laurel
L
Thomas
Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506, USA.
Bhupinder
B
Bawa
Anatomy and Physiology, Kansas State University, Manhattan, KS 66506, USA.
James D
JD
Lillich
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000633:toxicity*; D002154:Calpain / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D004386:Duodenum / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004847:Epithelial Cells / Q000187:drug effects* / Q000502:physiology; D007213:Indomethacin / Q000633:toxicity; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D009578:Nitrobenzenes / Q000633:toxicity; D034741:RNA, Small Interfering / Q000235:genetics; D017208:Rats, Wistar; D013449:Sulfonamides / Q000633:toxicity
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009578:Nitrobenzenes; D034741:RNA, Small Interfering; D013449:Sulfonamides; C080955:N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; D002154:Calpain; C000606071:Capn1 protein, rat; C000594975:Capn2 protein, rat; D007213:Indomethacin
Bromodeoxyuridine; Calpain; Cell migration inhibition; Duodenum; Nsaid